Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

SUCCINYLcholine Chloride 200 mg/10mL

CGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.

Terminated cGMP deviation New England Life Care, Inc. dba Advanced Compounding Solutions D-0926-2023
Class II · Moderate risk

Dry Eye Relief Lubricant Eye Drops

CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

Ongoing cGMP deviation K.C. Pharmaceuticals, Inc NDC 49035-280-02 D-0898-2023
Class II · Moderate risk

Original Eye Drops

CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.

Ongoing cGMP deviation K.C. Pharmaceuticals, Inc NDC 49348-037-29 D-0897-2023
Class II · Moderate risk

Levsin injection

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation Viatris Inc NDC 0037-9001-05 D-0866-2023
Class II · Moderate risk

Foaming Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Alpha Aromatics D-0760-2023
Class II · Moderate risk

HYDROmorphone HCl 10 mg in 0.9% Sodium Chloridge

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Ongoing cGMP deviation SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0776-2023
Class II · Moderate risk

Safe tussin PM

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0775-2023
Class II · Moderate risk

Pin-Away PYRENTAL PAMOATE

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC NDC 70309-080-02 D-0774-2023
Class II · Moderate risk

Colic Calm

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0773-2023
Class II · Moderate risk

Safe tussin DM

CGMP Deviations: Use of non-food grade lubricant in mixing vessel.

Ongoing cGMP deviation Denison Pharmaceuticals, LLC D-0772-2023